Document is current
Any future updates will be listed below
-
Authors
Funada, Satoshi https://orcid.org/0000-0002-8925-2348
Watanabe, Norio
Goto, Takayuki
Negoro, Hiromitsu
Akamatsu, Shusuke
Ueno, Kentaro
Uozumi, Ryuji
Ichioka, Kentaro
Segawa, Takehiko
Akechi, Tatsuo
Furukawa, Toshiaki A.
Ogawa, Osamu
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (20K18964)
Fujiwara Memorial Foundation (No.10)
- License Information
-
More Information
Article History
Received: 9 July 2020
Accepted: 14 August 2020
First Online: 20 August 2020
Ethics approval and consent to participate
: This study was approved by the ethics committee of Kyoto University Graduate School of Medicine (No. C1423) and was registered in the clinical trial registry (UMIN000035734).Written informed consent will be obtained from all participants.
: Not Applicable.
: SF has a research grant from JSPS KAKENHI Grant Number JP 20 K18964.NW has received a research grant from the Fujiwara Memorial Foundation for this work. He has also received royalties from Sogensha and Advantage Risk Management, for other than this work. RU has received personal fees from Eisai, Sawai Pharmaceutical, and CAC Croit, for other than this work. TA has received lectures fees from Astellas, AstraZeneca, Daiichi-Sankyo, Dainippon-Sumitomo, Hisamitsu, Janssen, Kyowa-hakko Kirin, Kyowa, Lilly, MSD, Meiji-seika Pharma, Mochida, Mundipharma, Nipro, Otsuka, Pfizer, Shionogi, Takeda, and Tsumura. He has received royalties from Igaku-shoin, and also has received research funds from Daiichi-Sankyo, Eisai, FUJIFILM RI Pharma, MSD, Otsuka, and Shionogi. TAF reports personal fees from Mitsubishi-Tanabe, MSD and Shionogi, and a grant from Mitsubishi-Tanabe, for other than the submitted work; TAF has a patent 2018–177688 pending. All of the other authors declare that they have no competing interests.
